# A Study of Donepezil Hydrochloride in Patients With Dementia Associated With Cerebrovascular Disease

> **NCT02660983** · PHASE4 · COMPLETED · sponsor: **Eisai Co., Ltd.** · enrollment: 302 (actual)

## Conditions studied

- Dementia Associated With Cerebrovascular Disease

## Interventions

- **DRUG:** Donepezil hydrochloride
- **DRUG:** Donepezil matching placebo
- **DRUG:** Donepezil hydrochloride

## Key facts

- **NCT ID:** NCT02660983
- **Lead sponsor:** Eisai Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08-05
- **Primary completion:** 2018-07-13
- **Final completion:** 2018-12-21
- **Target enrollment:** 302 (ACTUAL)
- **Last updated:** 2020-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02660983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02660983, "A Study of Donepezil Hydrochloride in Patients With Dementia Associated With Cerebrovascular Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02660983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*